Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
58.21
+0.01 (0.02%)
Apr 29, 2026, 3:00 PM CST

SHA:688799 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
188.26203.78177.74379.65191.29353.39
Short-Term Investments
--296.78349.66181.66-
Trading Asset Securities
201018315325400
Cash & Short-Term Investments
208.26213.78657.52744.31697.95753.39
Cash Growth
-31.61%-67.49%-11.66%6.64%-7.36%853.42%
Accounts Receivable
236.12279.1226.19183.54180.54129.2
Other Receivables
3.553.2116.52.142.191.49
Receivables
239.68282.31242.69185.68182.73130.68
Inventory
390.97392.46412.43362.67339.26300.53
Prepaid Expenses
--2.481.111.832.49
Other Current Assets
267.78287.68118.1555.9826.5718.89
Total Current Assets
1,1071,1761,4331,3501,2481,206
Property, Plant & Equipment
1,1771,003687596.78563.76472.98
Long-Term Investments
641.69542.1943.4947.1536.0534.11
Goodwill
--32.3832.3832.38-
Other Intangible Assets
167.18168.59186.0976.6281.0657.56
Long-Term Deferred Tax Assets
37.4840.4539.8118.7314.212.29
Long-Term Deferred Charges
40.4124.9410.445.323.260.23
Other Long-Term Assets
70.2298.5727.1450.2129.9214.38
Total Assets
3,2403,0542,4602,1772,0091,798
Accounts Payable
162.12181.53139.9289.571.1380.9
Accrued Expenses
14.5329.4324.5126.0420.6172.81
Short-Term Debt
--3.77---
Current Portion of Long-Term Debt
0.520.370.050.01--
Current Income Taxes Payable
3.8712.3213.329.971.290.94
Current Unearned Revenue
69.1664.9388.9980.1382.4162.75
Other Current Liabilities
140.96122.13148.46130.73119.442.19
Total Current Liabilities
391.17410.7419.02336.38294.83259.59
Long-Term Debt
672497.6113.9317.11--
Long-Term Unearned Revenue
101.17102.6598.849.9453.1956.92
Long-Term Deferred Tax Liabilities
--0.02-2.330.01
Other Long-Term Liabilities
--5.285.28-1.55
Total Liabilities
1,1641,011637.06408.7350.35318.07
Common Stock
131.32131.3293.893.893.893.8
Additional Paid-In Capital
876.37870.1850.34850.34850.34850.34
Retained Earnings
1,0681,041859.27779.37652.47535.33
Total Common Equity
2,0762,0431,8031,7241,5971,479
Minority Interest
--19.1744.7362.01-
Shareholders' Equity
2,0762,0431,8231,7681,6591,479
Total Liabilities & Equity
3,2403,0542,4602,1772,0091,798
Total Debt
672.52497.98117.7517.12--
Net Cash (Debt)
-464.26-284.2539.77727.19697.95753.39
Net Cash Growth
---25.77%4.19%-7.36%853.42%
Net Cash Per Share
-3.44-2.114.115.535.326.73
Filing Date Shares Outstanding
134.38131.32131.32131.32131.32131.32
Total Common Shares Outstanding
134.38131.32131.32131.32131.32131.32
Working Capital
715.52765.521,0141,013953.5946.38
Book Value Per Share
15.4515.5613.7313.1212.1611.27
Tangible Book Value
1,9091,8741,5851,6151,4831,422
Tangible Book Value Per Share
14.2014.2712.0712.2911.2910.83
Buildings
--329.86325.35313.1304.86
Machinery
--526.21491.33372.49274.63
Construction In Progress
--143.0627.6270.543.05
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.